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Comparison of recognition tools for postoperative pulmonary complications 
following thoracotomy. 
 
Background:   
The term postoperative pulmonary complication (PPC) encompasses any pulmonary 
abnormality occurring in the postoperative period producing identifiable disease or 
dysfunction which is clinically significant. The most frequently seen PPCs following lung 
resection are atelectasis and pneumonia, with the incidence of PPC (19-59%) much higher 
than that seen following upper (16-17%) or lower abdominal surgery (0-5%) [1]. 
Major thoracic surgical procedures may lead to PPC and reduced pulmonary function through 
atelectasis, secretion retention, altered chest wall mechanics, and abnormal breathing pattern 
[2]. Thoracic procedures carry a particularly high risk of PPC as surgery directly affects the 
lungs and associated structures, and patients are generally older and have cardiopulmonary 
disease associated with smoking, leading to loss of airway elasticity [3]. These procedures are 
associated with significant complications
 
increasing hospital length of stay (LOS), cost of 
hospitalisation [4], and need for intensive care unit admission [5]. PPC is the major cause or 
contributing factor of mortality following lung resection, accounting for up to 84 % of all 
deaths [5].  
Definition of PPC varies widely (hence large variation in reported frequency) and is usually 
dependent upon a set of criteria which may include such signs as chest x-ray findings, pyrexia 
and positive sputum microbiology. Various scoring tools have been developed from these 
type of signs whereby PPC is diagnosed if a certain number of criteria are met. A valid and 
reliable tool for PPC scoring may be useful for physiotherapists in recognising PPCs 
amenable to physiotherapy (atelectasis and pneumonia) in thoracic surgical patients. 
Physiotherapeutic strategies are thought to be physiologically important in the prevention and 
treatment of these problems, and a scoring tool may improve communication, prioritisation 
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and timely intervention in these patients. Although evidence for physiotherapy is limited in 
this area, there is a small amount suggesting benefit in terms of improving postoperative 
pulmonary function [6], and incidence of atelectasis [7]. A validated and reliable PPC scoring 
tool, which could be used for research purposes, would also improve comparability of results. 
The aim of our study was to evaluate the recognition of PPCs following thoracotomy and 
lung resection by comparing 3 scoring tools, previously used to assess frequency of PPC in 
clinical trials, and determine which tool correlates best with clinical outcome. 
Methods  
Design 
A prospective observational study was performed in a regional thoracic centre between 
October 2007 and April 2008. The study was approved by the clinical governance team of the 
hospital; ethical approval was not sought or deemed necessary by clinical governance team as 
this study was purely observational. 
Patient Selection  
All patients undergoing elective thoracotomy and lung resection were observed 
prospectively. Demographic data including age, gender, operative procedure, percentage 
predicted forced expiratory volume in 1 second was collected. Outcomes observed included 
need for therapeutic bronchoscopy for secretion clearance, antibiotic therapy for respiratory 
infection, as well as postoperative, high dependency unit (HDU) and intensive care LOS and 
mortality.  
Exclusion Criteria 
Emergency surgery, video assisted thoracoscopic procedures, and procedures of the 
mediastinum and chest wall were excluded.  
Surgical procedures  
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All surgical procedures were performed under general anaesthesia with single lung 
ventilation. All patients were scheduled for extubation in the recovery room at the end of the 
operation.  
Postoperative Care 
All patients were nursed in a thoracic HDU with pain relief provided either by an epidural 
infusion, intrathecal morphine and/or intercostal blocks or systemic opioids (parenteral 
administration or intravenous patient-controlled administration). All patients had an active 
program of daily postoperative physiotherapy including deep-breathing exercises, incentive 
spirometry, early mobilisation and sputum clearance techniques.  
Antibiotics were commenced when there was clinical and radiological evidence of pulmonary 
infection and were guided by microbiological advice. Postoperative toilet bronchoscopy was 
performed when lobar collapse due to sputum plugging did not respond to physiotherapeutic 
interventions. Patients were readmitted to or had prolonged stay in HDU (or admitted to ICU 
as appropriate) if they required organ or nursing support.  
Assessments of Postoperative Pulmonary Complications 
Assessment of PPC status was performed daily following surgery at midday by the same two 
independent physiotherapists (P.A. and H.C.) using 3 different sets of PPC scoring criteria, 
described by Brooks- Brunn [8], Gosselink et al [9], and Reeve et al [10]. For the purposes of 
this paper we have called these diagnostic scoring tools the Brooks- Brunn score (BBS), 
Gosselink score (GS) and Melbourne group scale (MGS) respectively. In personal 
correspondence with individuals who had contributed to its development, it was indicated 
that the latter tool should be referred to as the Melbourne group scale, not the Reeve score (in 
order to reflect the group contributions). The BBS was developed to diagnose atelectasis and 
pneumonia following upper abdominal surgery, the GS ‘clinically significant pulmonary 
complications’ with ‘infectious variables’ following thoracic surgery, and the MGS PPCs 
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following thoracotomy and lung resection that are ‘most likely to be prevented by 
physiotherapy, such as atelectasis and sputum retention, rather than PPCs less amenable to 
physiotherapy, such as pulmonary oedema and pleural effusion’ [11]. The variables for each 
scoring tool are shown in Table 1. The BBS and MGS recognise PPC when a certain number 
of possible set criteria are positive; 2 of the BBS variables positive for 2 consecutive days (it 
is not stated if these 2 variables have to be the same for the 2 day period), and 4 or more of 
the 8 MGS variables positive on any day. The GS relies upon all specific criteria being 
positive (including the chest x-ray score) (Table 1). The thoracic physicians were blinded to 
the scores so it did not influence treatment given or assessment of chest radiographs . The 
assessment of criteria for the BBS and GS was performed as described in the papers by 
Brooks- Brunn [8] and Gosselink et al [9]. Further clarification regarding the GS was needed 
in order to confirm how microbiology results contribute to the score as it was unclear as 
described in the paper by Gosselink et al [9]; a positive sputum microbiology report 
constituted a positive second criteria, even if white cell count (WCC) is negative (personal 
communication with author), see Table 1. Detailed information/instruction regarding the 
application of the MGS [11] was used to facilitate its application, and where necessary advice 
was sought (personal communication with author). 
Statistical Analysis 
Continuous variables are expressed as mean (± standard deviation), or median (95% 
confidence interval) if skewed, and categorical variables are expressed as percentages. 
Mortality and frequency of intensive care admission were compared with the Fisher’s exact 
test and postoperative and HDU LOS with the Mann Whitney U test. A p value <0.05 was 
considered significant.  
 
Results   
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Demographics 
129 consecutive patients were observed; 58% (75) male, mean age 60.9 (±15.4) years, mean 
predicted forced expiratory volume in 1 second 83 (±20)%. 
Operative Procedures 
Surgical procedures included pneumonectomy in 12% (15), lobectomy in 50% (64), 
segmentectomy in 4% (5), wedge resection in 29% (38), exploratory thoracotomy in 3% (4) 
and sleeve resection in 2% (3) of cases.  
Score Recognition of PPC 
The incidence of PPC was 6% (8) when scored by the GS, 13% (17) with the MGS and 39% 
(51) with the BBS. The incidence of PPC in our cohort was 12% (16) as defined by the 
clinical outcome diagnosis of PPC (clinical or microbiological evidence of pulmonary 
infection resulting in prescription of antibiotic therapy (15), or clinically significant 
atelectasis requiring toilet bronchoscopy (1). The MGS correlated best with clinical outcome 
diagnosis of PPC. All cases of PPC defined by clinical outcome were detected by the MGS 
and BBS, but only half of cases by the GS.  See Table 2 for specificity and sensitivity of the 
three scores. 
Length of stay 
There was a significantly longer postoperative length of stay in patients with PPC as 
recognised by all 3 scoring tools, and significantly longer HDU LOS in those with PPC as 
recognised by the GS and MGS, supporting the idea that the BBS is over diagnosing and 
diluting the differences in morbidity as expressed in HDU LOS (Table 3). 
Mortality 
There were 3 in-hospital deaths in the patient cohort, 2 patients succumbed to postoperative 
pneumonia, the other myocardial infarction. The GS did not determine PPC in the patients 
diagnosed with pneumonia, the BBS determined PPC in all of these patients, and the MGS 
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correctly determined PPC in the 2 patients with the clinical diagnosis of pneumonia only. The 
MGS demonstrated a significant difference (p=.046) in mortality between the group in which 
it determined PPC (12%) and the group in which it did not determine PPC (1%). 
Definition of PPC using the MGS  
It appears that the MGS score of 4 was the appropriate level for this score to determine PPC 
as no patients with a maximum score of 3 developed a PPC as defined by clinical outcome. 
Also the median postoperative LOS was significantly lower in patients whose maximum 
score was 3 versus 4, at 6 (5-7) days compared to 14 (12-19) (p<0.001). 
Day of PPC manifestation  
Most patients presented with PPC as defined by the MGS with a score ≥4 during the early 
postoperative period, with only two manifesting late on postoperative days 10 and 17 (Figure 
1). The most commonly positive MGS variables in patients with a score ≥4 were chest x-ray 
signs of atelectasis or infiltration (88%), purulent sputum (88%), elevated WCC (88%) and 
low oxygen saturation (70%). Frequency of the other variables is as follows; physician 
diagnosis of pneumonia or chest infection 59%, temperature >38ºC 47%, positive signs on 
sputum microbiology 29% and readmission/ prolonged stay intensive care or HDU (>36hrs) 
18%. No MGS positive scores were reliant on the variable for administration of antibiotics 
for pulmonary infection. 
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Discussion   
The incidence of PPC as defined by those treated with antibiotic therapy for respiratory 
infection or bronchoscopy to clear secretions was 12%. The MGS correlated well with the 
clinical outcome diagnosis of PPC compared with the BBS, which over diagnosed PPC, and 
GS which under diagnosed PPC. Scoring positive with the MGS (score ≥4) was associated 
with prolonged postoperative LOS, HDU LOS and increased mortality.  
The BBS criteria, which were developed for the purpose of PPC recognition after upper 
abdominal surgery, rely on only 2 factors scored positive (for 2 consecutive days), and 
include new cough or sputum production, altered breath sounds,  temperature ≥38oC, chest x-
ray documentation of atelectasis or new infiltrate, and  physician documentation of atelectasis 
or pneumonia [8]. We tested it in the context of thoracic surgery to determine if it was 
transferable. However, the BBS may over diagnose PPC in thoracic surgical patients as a 
significant proportion of them have altered breath sounds due to nature of the surgery, and 
this was the most frequently positive BBS variable on analysis of our data. Also only 2 
criteria are required with this tool for a positive PPC score. 
The GS criteria for identification of PPC were developed as an outcome measure for a 
randomised controlled trial comparing incentive spirometry with standard breathing exercises 
(n=67) after thoracic and oesophageal surgery. Authors in this negative trial felt there was a 
low incidence of PPC in lung resection patients (8%) when compared to other published data. 
However this figure is comparable to the GS PPC frequency in our data, and differs with 
other published work as PPC definition varies. PPC as determined with the GS may be less 
than those treated in our cohort because of the stringent inclusion of all 3 criteria for scoring 
positive, these comprising ‘major’ chest x-ray infiltrates,  increased WCC or administration 
of antibiotic therapy , and temperature  >38oC [9].  The false negative GS PPC scores were 
either due to chest x-ray scoring, temperature scoring, or a combination of both. 
 8 
The MGS has recently been used as an outcome measure in a randomised controlled trial 
(n=76) studying the effect of physiotherapy following thoracotomy and lung resection [11]. It 
was adapted from PPC diagnostic tools used in similar studies [12,13,14]involving other 
surgical groups  [11]. The incidence of PPC in both limbs of this trial  [11] was much lower 
than anticipated by the authors (4.8% in the treatment group and 2.9% in the control group). 
The potential explanations for the low PPC rate included possible advancements in analgesia, 
more emphasis on early postoperative mobility and use of a standardised clinical pathway. 
This rate is much lower than our current study despite similar demographics, diagnostic 
criteria and postoperative care pathway. Our results have been consistently reported at this 
level in a larger group [15].   
The MGS has the advantage of not being reliant on radiological findings and does not include 
altered breath sounds. The categories which were most frequently positive were all objective 
observations including chest x-ray signs of atelectasis or consolidation, purulent sputum, 
elevated WCC (>11.2) or administration of respiratory antibiotics,  and low oxygen 
saturation (< 90%  on air). Though the MGS has physician diagnosis of pneumonia or chest 
infection as a scoring factor we found most patients scored in other objective measures and 
only 1 of the 17 had the contribution of physician diagnosis scoring to become positive for 
PPC. Each factor is not weighted because this is not designed to be a risk assessment tool but 
a diagnostic aid.  
The ‘modified early warning score’ is a valuable tool used to alert nurses and clinicians of 
patient deterioration[16]. Similarly the MGS may be a useful, easy to use tool in defining 
respiratory deterioration in thoracic surgical patients. In our data set 46% of patients who 
scored 3 with the MGS, went on to score ≥4. Whether screening may identify patients at high 
risk of developing a PPC and whether intervention, such as physiotherapy, can prevent 
progression in this group is yet to be tested. In addition we have assessed clinical risk factors 
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for the development of PPC in this group of patients and demonstrated factors associated with 
PPC, such as age ≥75 body mass index ≥30, American Society of Anaesthesiologists score 
≥3, COPD and current smoking [15]. Therefore it may be possible to target therapy in a high 
risk group based on risk factors and the MGS. 
The MGS is a simple tool which any physiotherapist, nurse or physician can use since it is 
based principally on objective measures which are already observed and assessed during the 
postoperative period. Physiotherapists in our centre collect MGS data routinely on all major 
thoracic surgical patients, which is available to the multidisciplinary team. 
We accept that comparing these scoring tools against the treatment modalities for PPC may 
miss patients who develop minor PPC, but if not treated these cases may not be of clinical 
relevance. Patients with chronic lung disease may score false positive. In this study the MGS 
diagnosed PPC in a patient who did not receive antibiotics or bronchoscopy, but who was a 
current smoker with chronic obstructive pulmonary disease and sputum retention. The MGS 
was not designed to detect other pulmonary complications such as broncho pleural fistula or 
prolonged air leak, but is designed for detecting PPCs amenable to physiotherapy which 
warrant escalation of physiotherapy treatment and possible mini-tracheostomy and/or flexible 
bronchoscopy.   Also by using a common scoring tool and definition of PPC comparison of 
research results could be improved. 
 
Conclusion: 
Treatment for PPC following thoracotomy is common. Of the three scoring tools, that 
described by Reeve et al [10] (MGS) best correlates with the clinical outcome diagnosis of 
PPC described in this paper. Patients with a PPC positive MGS have a worse outcome as 
defined by mortality, HDU and postoperative length of stay. The MGS is an easy to use 
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multidisciplinary scoring tool, but further work into its use in minimally invasive surgery and 
in targeting high risk groups for therapy is required. 
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Table 1: PPC scoring criteria as described by Reeve et al [10], Gosselink et al [9] , and 
Brooks-Brunn [8]  
 
 
MGS- Reeve et al [10] 
 
GS- Gosselink et al [9] BBS- Brooks-Brunn [8] 
Temperature >38
o
C Temperature >38
o
C Temperature ≥38oC  
WCC>11.2 or respiratory 
antibiotics 
WCC>12 (or positive microbiology)  
Physician diagnosis of 
pneumonia or chest infection 
 
Physician documentation 
atelectasis/pneumonia 
Chest x-ray report of 
atelectasis/consolidation 
Chest x-ray Score 
0-no abnormality 
1-minor unilateral atelectasis 
2- minor bilateral atelectasis  
3- major unilateral atelectasis or 
infiltration  
4- major bilateral atelectasis or 
infiltration 
Chest x-ray documentation of 
atelectasis /new infiltration 
 
Production of purulent 
(yellow/green) sputum differing 
from preoperative 
New Cough / Sputum 
 
+ve signs on sputum 
microbiology 
  
SpO2 < 90% on room air   
Readmission to or prolonged 
stay (over 36 hours) on the 
intensive care unit/HDU for 
respiratory problems 
  
  
Abnormal Breath sounds 
compared to baseline 
PPC = 4 or more positive 
variables 
PPC = Chest x-ray score of 3 or 4 
and positive in other 2 variables 
PPC = 2 variables positive for 
two consecutive days 
MGS- Melbourne group scale [10] 
GS- Gosselink score [9] 
BBS- Brooks-Brunn score [8] 
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Table 2: Specificity and sensitivity of the three scores. 
Score Specificity Sensitivity 
MGS- Reeve et al [10] 
 
99% 100% 
GS- Gosselink et al [9] 100% 50% 
BBS- Brooks-Brunn [8] 69% 100% 
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Table 3: Postoperative and HDU LOS for PPC and Non PPC patients (as determined 
with each scoring tool) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GS- Gosselink score [9] 
MGS- Melbourne group scale [10] 
BBS- Brooks-Brunn score [8] 
 Median (95%CI) postoperative LOS (days) Median (95%CI) HDU LOS (days) 
Score PPC Non- PPC p value PPC Non- PPC p value 
GS [9] 17(10-22) 5 (5.5-7) <0.001 4 (2-9) 1 (1.7-2.3) 0.002 
MGS[10] 12 (11-18) 5 (5-6) <0.001 5 (3-7) 1 (1.5-2) <0.001 
BBS [8] 7 (7-10) 5 (5-6) 0.001 2 (2-3.5) 1 (1.5-2) 0.187 
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Figure 1: The timing of presentation of patients first scoring ≥4 with the Melbourne group 
scale in the postoperative course. 
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